Abstract
Background
Since the Food and Drug Administration (FDA) approval of laparoscopic adjustable gastric bands (LAGB) in June 2001, the number LAGB procedures performed in the United States has increased exponentially. This study aimed to benchmark the authors’ initial hospital experience to FDA research trials and evidence-based literature.
Methods
Over a 2-year period, 87 consecutive patients with a mean age of 43 years (range, 21–64 years) and a body mass index of 45.6 kg/m2 (range, 35–69 kg/m2) underwent an LAGB procedure at the authors’ institution. The authors conducted a retrospective review of the outcomes including conversion, reoperation, mortality, perforation, erosion, prolapse, port dysfunction, excess weight loss, and changes in comorbidities, then compared the data with published benchmarks.
Results
Gender, age, and body mass index were comparable with those of other series. Perioperative adverse events included acute stoma obstruction (n = 1) and respiratory complications (n = 2). Delayed complications included gastric prolapse (n = 4) and port reservoir malposition (n = 4). Five bands were explanted. The mean follow-up period was 14 months (n = 79). The mean percentage of excess weight loss was 30% (range, 4.7–69%) at 6 months, 41% (range, 9.6–82%) at 12 months, and 47% (range, 14–92%) at 24 months. Comorbidities resolved included diabetes (74%), hypertension (57%), gastroesophageal reflux disease (55%) and dyslipidemia (38%).
Conclusions
The short-term outcomes for LAGB were comparable with published benchmarks. With adequate weight loss, most patients achieve significant improvement in obesity-related illnesses. With new bariatric accreditation standards and mandates required for financial reimbursement, hospitals will need to demonstrate that their clinical outcomes are consistent with best practices. The authors’ early experience shows that LAGB achieves significant weight loss with low mortality and morbidity rates. Despite a more gradual weight loss, most patients achieve excellent weight loss with corresponding improvement of comorbidities within the first 2 years postoperatively.
Similar content being viewed by others
References
Angrisani M, Alkilani N, Basso N, Belvederesi N, Campanile F, Capizzi FD, D”Atri C, Di Cosmo L, Doldi SB, Favretti F, Forestieri P, Furbetta F, Giacomelli F, Giardiello C, Iuppa A, Lesti G, Lucchese M, Puglisi F, Scipioni L, Tippino M, Turicchia GU, Veneziani A, Docimo C, Borreli V, Lorenzo M (2001) Laparoscopic Italian experience with the LAP-BAND. Obes Surg 11: 307–310
Belachew M, Belva PH, Desaive C (2002) Long-term results of laparoscopic adjustable gastric banding for the treatment of morbid obesity. Obes Surg 12: 564–568
Belachew M, Legrand MJ, Defechereux TH, Burtheret MP, Jacquet N (1994) Laparoscopic adjustable gastric banding in the treatment of morbid obesity: a preliminary report. Surg Endosc 8: 1354–1363
Blackstone R (2006) Implications of the Medicare national coverage decision for bariatric surgery for treatment of morbid obesity. Bariatric Nurs Surg Patient Care 1: 151–155
Buchwald H, Avidor Y, Braunwald E, Jensen M, Pories W, Fahrbach K, Schoelles K (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292: 1724–1737
Chapman AE, Kiroff G, Game P, Foster B, O’Brien P, Ham J, Maddern GJ (2004) Laparoscopic adjustable gastric banding in the treatment of obesity: a systemic review. Surg 135: 326–351
Commonwealth of Massachusetts Betsy Lehman Center for Patient Safety and Medical Error Reduction Expert Panel on Weight Loss Surgery Executive Report (2005) Obes Surg 13: 205–226
Dixon JB, O’Brien PE (2002) Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg 184: 51S–54S
Favretti F, Cadiere GB, Segato G, Himpens J, De Luca M, Busetto L, De Marchi F, Foletto M, Caniato D, Lise M, Enzi G (2002) Laparoscopic gastric banding: selection and technique in 830 patients. Obes Surg 12: 385–390
Fielding GA, Rhodes M, Nathanson LK (1999) Laparoscopic gastric banding for morbid obesity: surgical outcomes in 335 cases. Surg Endosc 13: 550–554
Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Draft Statement (1991). Obes Surg 1: 257–266
Jenkins JT, Modak P, Galloway DJ (2006) Prospective study of laparoscopic adjustable gastric banding in the west of Scotland. Scott Med J 51: 37–41
Jones DB, DeMaria E, Provost DA, Smith CD, Margenstern L, Schirmer B (2004) Optional management of the morbidly obese patient: SAGES appropriateness conference statement. Surg Endosc 18: 1029–1037
Kelly J, Tarnoff M, Shikora S, Thayer B, Jones DB, Forse AR, Hutter MA, Fanelli R, Lautz D, Buckley F, Munshi I, Coe N (2005) Best practice recommendations for surgical care in weight loss surgery. Obes Res 13: 227–233
Mokdad AH, Marks J, Stroup D, Gerberding J (2004) Actual causes of death in the United States, 2000. JAMA 291: 1238–1245
Mokdad AH, Marks J, Stroup D, Gerberding J (2005) Correction: actual causes of death in the United States, 2000. JAMA 293: 293–294
Nguyen NT, Morton JM, Wolfe MB, Schirmer B, Ali M, Traverso LW (2005) The SAGES Bariatric Surgery Outcome Initiative. Surg Endosc 19: 1429–1438
Nguyen NT, Root J, Zainabadi K, Sabio A, Chalifoux S, Stevens CM, Mavandadi S, Longoria M, Wilson SE (2005) Accelerated growth of bariatric surgery with the introduction of minimally invasive surgery. Arch Surg 140: 1198–1202
O’Brien PE, Brown WA, Smith A, McMurrick PJ, Stephens M (1999) Prospective study of laparoscopic placed, adjustable gastric band in the treatment of morbid obesity. Br J Surg 86: 113–118
O’Brien PE, Dixon JB (2002) Weight loss and early and late complications: the international experience. Am J Surg 184: S42–S45
O’Brien PE, Dixon JB (2003) LAP-BANd: outcomes and results. J Laparoendosc Adv Surg Tech A 13: 265–270
O’Brien PE, Dixon JB, Laurie C, Skinner S, Proietto J, McNeil J, Strauss B, Marks S, Schachter L, Champman L, Anderson M (2006) Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program. Ann Intern Med 144: 625–634
Ponce J, Paynter S, Fromm R (2005) Laparoscopic adjustable gastric banding: 1,014 consecutive cases. J Am Coll Surg 201: 529–535
Pontiroli AE, Folli F, Paganelli M, Micheletto G, Pizzocri P, Vedani P, Luisi F, Perego L, Morabito A, Bressani Doldi S (2005) Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study. Diabetes Care 28: 2703–2709
Provost DA (2005) Laparoscopic adjustable gastric banding: an attractive option. Surg Clin North Am 85: 789–805
Ren CJ, Horgan S, Ponce J (2002) U.S. experience with the LAP-BAND system. Am J Surg 184: S46–S50
Rubenstein RB, Ferraro DR, Raffel J (2002) Laparoscopic adjustable gastric banding at a U.S. center with up to 30-year follow-up. Obes Surg 12: 380–384
Sarker S, Herold K, Creech S, Shayani V (2004). Early and late complications following laparoscopic adjustable gastric banding. Am Surg 70: 146–150
Spivak H, Anwar F, Burton S, Guerrero C, Onn A (2004) The LAP-BAND System in the United States: one surgeon’s experience with 271 patients. Surg Endosc 18: 198–202
Steinbrook R (2004) Surgery for severe obesity. N Eng J Med 350: 1075–1079
Watkins BM, Montgomery KF, Ahroni JH (2005) Laparoscopic adjustable gastric banding: early experience in 400 consecutive patients in the USA. Obes Surg 15: 82–87
Author information
Authors and Affiliations
Corresponding author
Additional information
Poster Presentation at Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Annual Meeting, Dallas, TX 2006
Rights and permissions
About this article
Cite this article
Edwards, M.A., Grinbaum, R., Schneider, B.E. et al. Benchmarking hospital outcomes for laparoscopic adjustable gastric banding. Surg Endosc 21, 1950–1956 (2007). https://doi.org/10.1007/s00464-007-9302-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-007-9302-0